10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $123,480,209 | -29.0% | 2,993,460 | -3.9% | 0.94% | -17.9% |
Q2 2023 | $173,860,560 | -25.0% | 3,113,549 | -25.1% | 1.15% | -27.7% |
Q1 2023 | $231,825,470 | +47.4% | 4,155,323 | -3.7% | 1.59% | +16.9% |
Q4 2022 | $157,295,701 | +20.7% | 4,316,567 | -5.7% | 1.36% | +49.9% |
Q3 2022 | $130,348,000 | -29.3% | 4,576,814 | +27.0% | 0.91% | -16.7% |
Q2 2022 | $184,452,000 | -28.5% | 3,603,286 | +6.2% | 1.09% | +1.3% |
Q1 2022 | $257,979,000 | -34.9% | 3,391,338 | +27.5% | 1.08% | -10.1% |
Q4 2021 | $396,363,000 | -12.2% | 2,660,866 | -14.2% | 1.20% | +10.5% |
Q3 2021 | $451,582,000 | -46.4% | 3,101,951 | -27.9% | 1.08% | -30.8% |
Q2 2021 | $842,033,000 | +32.8% | 4,300,037 | +22.7% | 1.57% | +24.4% |
Q1 2021 | $634,246,000 | +739.6% | 3,504,121 | +556.8% | 1.26% | +526.9% |
Q4 2020 | $75,543,000 | +162.2% | 533,496 | +130.9% | 0.20% | +17.5% |
Q3 2020 | $28,813,000 | -4.1% | 231,097 | -31.3% | 0.17% | -47.1% |
Q2 2020 | $30,058,000 | – | 336,553 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |